close 74% jaeinvestorite kontodest jääb antud teenusepakkuja juures hinnavahelepingutega kauplemisel kahjumisse. Investeerimisega kaasnevad riskid ja need ei ole sobilikud kõigile investoritele. Hinnavahelepingud on keerukad instrumendid, millega kaasneb võimenduse tõttu suur risk kaotada raha kiiresti. 74% jaeinvestorite kontodest jääb antud teenusepakkuja juures hinnavahelepingutega kauplemisel kahjumisse. Palume teil kaaluda, kas hinnavahelepingute süsteem on teile arusaadav ja kas olete valmis võtma riski, mis suure tõenäoususega on kahjumlik.
Change languageEesti
Ülevaade

JNJ

227.46

-1.06%↓

UNH

369.01

-0.49%↓

TMO

469.28

-1.91%↓

ISRG

457.59

+0.02%↑

ABT

89.51

-1.34%↓

JNJ

227.46

-1.06%↓

UNH

369.01

-0.49%↓

TMO

469.28

-1.91%↓

ISRG

457.59

+0.02%↑

ABT

89.51

-1.34%↓

JNJ

227.46

-1.06%↓

UNH

369.01

-0.49%↓

TMO

469.28

-1.91%↓

ISRG

457.59

+0.02%↑

ABT

89.51

-1.34%↓

JNJ

227.46

-1.06%↓

UNH

369.01

-0.49%↓

TMO

469.28

-1.91%↓

ISRG

457.59

+0.02%↑

ABT

89.51

-1.34%↓

JNJ

227.46

-1.06%↓

UNH

369.01

-0.49%↓

TMO

469.28

-1.91%↓

ISRG

457.59

+0.02%↑

ABT

89.51

-1.34%↓

Kodu・Aktsiate loetelu・Pulse Biosciences Inc
Search

Pulse Biosciences Inc

Suletud

SektorTervishoid

20.8 -1.38

Osta

Hinna uuendus 1. mai 2026, 19:59 UTC

OstaMüü

Ülevaade

Aktsiahinna muutus

24h

Praegune

Min

20.61

Max

20.87

Põhinäitajad

By Trading Economics

Sissetulek

2M

-17M

Müük

178K

264K

Aktsiakasum

-0.18

Kasumimarginaal

-6,603.409

Töötajad

116

EBITDA

2M

-17M

Soovitused

By TipRanks

Soovitused

Osta

12 kuu keskmine prognoos

+44.02% upside

Dividendid

By Dow Jones

Järgmine tulemuste avaldamine

7. mai 2026

Turustatistika

By TradingEconomics

Turukapital

582M

1.5B

Eelmine avamishind

22.18

Eelmine sulgemishind

20.8

Uudiste sentiment

By Acuity

50%

50%

155 / 347 Pingereas Healthcare

Tehniline skoor

By Trading Central

Kindlus

Very Strong Bearish Evidence

16.59 / 17.17 Toetus ja vastupanu

Pulse Biosciences Inc Graafik

Mineviku tootlus ei ole usaldusväärne näitaja tulevaste tulemuste kohta.

Seotud uudised

3. mai 2026, 23:47 UTC

Tulu

National Australia Bank Warns of Economic Shock as 1st Half Profit Falls -- Update

DJ

Loe

3. mai 2026, 22:35 UTC

Tulu

National Australia Bank Holds Dividend Despite 19% 1st Half Profit Drop

DJ

Loe

3. mai 2026, 23:39 UTC

Market Talk

Gold Edge Higher Amid Signs of Resilience -- Market Talk

DJ

Loe

3. mai 2026, 23:34 UTC

Market Talk

Oil Declines Amid Mild Risk-on Sentiment -- Market Talk

DJ

Loe

3. mai 2026, 23:32 UTC

Tulu

National Australia Bank Warns of Economic Shock as 1H Profit Falls -- Update

DJ

Loe

3. mai 2026, 23:30 UTC

Market Talk

Nickel Industries Result Shows Power of Higher Prices -- Market Talk

DJ

Loe

3. mai 2026, 23:20 UTC

Market Talk

RBA Likely to Hike Rates; Guidance and Board Split Key -- Market Talk

DJ

Loe

3. mai 2026, 23:16 UTC

Omandamised, ülevõtmised, äriostud

GameStop Is Offering to Buy eBay for $56 Billion, CEO Ryan Cohen Says -- WSJ

DJ

Loe

3. mai 2026, 22:57 UTC

Omandamised, ülevõtmised, äriostud

GameStop Is Offering to Buy eBay For $56 Billion, CEO Ryan Cohen Says -- WSJ

DJ

Loe

3. mai 2026, 22:57 UTC

Omandamised, ülevõtmised, äriostud

GameStop Has Roughly 5% Stake in eBay, Cohen Says -- WSJ

DJ

Loe

3. mai 2026, 22:57 UTC

Omandamised, ülevõtmised, äriostud

GameStop Offering to Buy eBay for $125 a Share, or About $56 Billion, CEO Ryan Cohen Says -- WSJ

DJ

Loe

3. mai 2026, 22:57 UTC

Omandamised, ülevõtmised, äriostud

GameStop Is Prepared to Run Proxy Fight If eBay Isn't Receptive to a Deal, Cohen Says -- WSJ

DJ

Loe

3. mai 2026, 22:57 UTC

Omandamised, ülevõtmised, äriostud

GameStop Has Around $20 Billion in Debt Financing Committed From TD Bank, Cohen Says -- WSJ

DJ

Loe

3. mai 2026, 22:45 UTC

Market Talk

Global Equities Roundup: Market Talk

DJ

Loe

3. mai 2026, 22:45 UTC

Market Talk

Low-Cost Miners in Spotlight Amid High Energy Prices -- Market Talk

DJ

Loe

3. mai 2026, 22:20 UTC

Tulu

National Australia Bank Holds Dividend Despite 19% 1H Profit Drop

DJ

Loe

3. mai 2026, 22:08 UTC

Tulu

NAB's 1H Included Previously Announced A$1.35B Software Amortization Charge>NAB.AU

DJ

Loe

3. mai 2026, 22:05 UTC

Tulu

NAB 1H Net Interest Income A$9.16B Vs. A$8.445B>NAB.AU

DJ

Loe

3. mai 2026, 22:05 UTC

Tulu

NAB 1H Credit Impairment Charge A$706M Vs. A$348M>NAB.AU

DJ

Loe

3. mai 2026, 22:05 UTC

Tulu

NAB 1H Operating Expenses A$5.02B Vs. A$4.81B>NAB.AU

DJ

Loe

3. mai 2026, 22:04 UTC

Tulu

NAB 1H Net Interest Margin 1.81%>NAB.AU>NAB.AU

DJ

Loe

3. mai 2026, 22:03 UTC

Tulu

NAB 1H Cash Return on Equity Ex-Large Notable Items 11.6%>NAB.AU

DJ

Loe

3. mai 2026, 22:03 UTC

Tulu

NAB 1H Cash Return on Equity 8.5%>NAB.AU

DJ

Loe

3. mai 2026, 22:02 UTC

Tulu

NAB 1H CET1 Capital Ratio 11.65% Vs. 12.01%>NAB.AU

DJ

Loe

3. mai 2026, 22:02 UTC

Tulu

NAB 1H Cash Earnings A$2.64B>NAB.AU

DJ

Loe

3. mai 2026, 22:02 UTC

Tulu

NAB 1H Cash Earnings Ex-Notable Items A$3.59B Vs. A$3.58B>NAB.AU

DJ

Loe

3. mai 2026, 22:01 UTC

Tulu

National Australia Bank Keeps Dividend at A$0.85 >NAB.AU

DJ

Loe

3. mai 2026, 22:01 UTC

Tulu

National Australia Bank 1H Rev A$11.16B Vs. A$10.28B >NAB.AU

DJ

Loe

3. mai 2026, 22:01 UTC

Tulu

National Australia Bank 1H Net A$2.75B Vs. Net A$3.41B >NAB.AU

DJ

Loe

3. mai 2026, 15:06 UTC

Tulu

Berkshire's Greg Abel Marks His First Annual Meeting as CEO. We'd Give Him a B-Plus. -- Barrons.com

DJ

Loe

Võrdlus sarnastega

Hinnamuutus

Pulse Biosciences Inc Prognoos

Hinnasiht

By TipRanks

44.02% tõus

12 kuu keskmine prognoos

Keskmine 30 USD  44.02%

Kõrge 30 USD

Madal 30 USD

Põhineb 2 Wall Streeti analüütiku instrumendi Pulse Biosciences Inc 12 kuu hinnasihil - viimase 3 kuu andmed.

Hinnangu Konsensus

By TipRanks

Osta

2 ratings

2

Osta

0

Hoia

0

Müü

Põhineb 2 analüütiku instrumendi Pulse Biosciences Inc aktsia reitingul - viimase 3 kuu andmed.

Tehniline skoor

By Trading Central

16.59 / 17.17Toetus ja vastupanu

Lühikene perspektiiv

Very Strong Bearish Evidence

Recent bearish events outweigh bullish events.

Keskpikk perspektiiv

Bearish Evidence

Recent bearish events outweigh bullish events.

Pikk perspektiiv

Weak Bearish Evidence

Recent bearish events outweigh bullish events.

Sentiment

By Acuity

155 / 347 Pingereas Tervishoid

Uudiste sentiment

Neutral

Volatiilsus

Alla keskmise

Uudismaht (RCV)

Alla keskmise

Finantsandmed

Müügi- ja halduskulud

Tegevuskulud

Maksueelne kasum

Müük

Müügikulu

Brutokasum müügist

Intressikulud võla pealt

EBITDA

Ärikasum

$

Ettevõttest Pulse Biosciences Inc

Pulse Biosciences, Inc. operates as a novel bioelectric medicine company. The company offers CellFX System, a tunable, software-enabled, and console-based platform that delivers nano second duration pulses of electrical energy to non-thermally clear targeted cells while sparing adjacent non-cellular tissue to treat a various medical condition by using its Nano-Pulse Stimulation technology. The company was formerly known as Electroblate, Inc. and changed its name to Pulse Biosciences, Inc. in December 2015. Pulse Biosciences, Inc. was incorporated in 2014 and is headquartered in Hayward, California.

Muud aktsiad sektorist

JNJ

Johnson and Johnson

227.46

↓-1.06%

UNH

UnitedHealth Group Inc

369.01

↓-0.49%

TMO

Thermo Fisher Scientific Inc

469.28

↓-1.91%

ISRG

Intuitive Surgical Inc

457.59

↑ +0.02%

ABT

Abbott Laboratories

89.51

↓-1.34%
help-icon Live chat